178 related articles for article (PubMed ID: 38193829)
1. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.
Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N
Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
5. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis.
Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T
Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027
[TBL] [Abstract][Full Text] [Related]
7. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.
Liao M; Liu Q; Li B; Liao W; Xie W; Zhang Y
Cancer Sci; 2018 Dec; 109(12):4033-4044. PubMed ID: 30290038
[TBL] [Abstract][Full Text] [Related]
8. Abnormally Expressed Long Non-Coding RNAs in Nasopharyngeal Carcinoma: a Meta-Analysis.
Xia L; Zhang W; Zhu L; Yu G
Clin Lab; 2018 Apr; 64(4):585-595. PubMed ID: 29739093
[TBL] [Abstract][Full Text] [Related]
9. Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).
Ning L; Hu YC; Wang S; Lang JH
Medicine (Baltimore); 2018 Aug; 97(32):e11481. PubMed ID: 30095613
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis.
Binabaj MM; Bahrami A; Bahreyni A; Shafiee M; Rahmani F; Khazaei M; Soleimanpour S; Ghorbani E; Fiuji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Biochem; 2018 Nov; 119(11):9583-9590. PubMed ID: 30129051
[TBL] [Abstract][Full Text] [Related]
11. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
Shobeiri P; Alilou S; Jaberinezhad M; Zare F; Karimi N; Maleki S; Teixeira AL; Perry G; Rezaei N
PLoS One; 2023; 18(3):e0281784. PubMed ID: 36947499
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
Nie G; Lian N; Peng D; Lu J; Li B
Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.
Qin J; Ke B; Liu T; Kong C; Li A; Fu H; Jin C
Cancer Med; 2023 Feb; 12(3):2199-2218. PubMed ID: 36057947
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Rezaei N
PLoS One; 2023; 18(9):e0291921. PubMed ID: 37733767
[TBL] [Abstract][Full Text] [Related]
15. Modular signature of long non-coding RNA association networks as a prognostic biomarker in lung cancer.
Li A; Yu WH; Hsu CL; Huang HC; Juan HF
BMC Med Genomics; 2021 Dec; 14(Suppl 3):290. PubMed ID: 34872564
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.
Bahramy A; Zafari N; Rajabi F; Aghakhani A; Jayedi A; Khaboushan AS; Zolbin MM; Yekaninejad MS
Front Mol Biosci; 2023; 10():1096524. PubMed ID: 36726376
[No Abstract] [Full Text] [Related]
17. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Hao H; Chen L; Shao J
Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.
Wang Y; Li Z; Li W; Zhou L; Jiang Y
Medicine (Baltimore); 2019 Oct; 98(40):e17276. PubMed ID: 31577719
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
Kang W; Zheng Q; Lei J; Chen C; Yu C
Dis Markers; 2018; 2018():5340894. PubMed ID: 30598708
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]